SBI Securities
FLGT icon

SBI Securities’s Fulgent Genetics FLGT Stock Holding History

SBI Securities’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.4K Sell
312
-700
-69% -$11.9K ﹤0.01% 2062
2026
Q1 		$16.1K Sell
1,012
-119
-11% -$2.58K ﹤0.01% 1548
2025
Q4 		$29.7K Buy
1,131
+20
+2% +$519 ﹤0.01% 1292
2025
Q3 		$25.1K Buy
1,111
+11
+1% +$227 ﹤0.01% 1360
2025
Q2 		$21.9K Sell
1,100
-51
-4% -$994 ﹤0.01% 1380
2025
Q1 		$19.5K Sell
1,151
-48
-4% -$818 ﹤0.01% 1340
2024
Q4 		$22.1K Buy
+1,199
New +$23.4K ﹤0.01% 1297

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SBI Securities's FLGT Position: Q2 2026 in Review

SBI Securities reduced its Fulgent Genetics (FLGT) stake by 69% in Q2 2026, selling an estimated $11.9K and leaving 312 shares worth $6.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

SBI Securities first reported a position in FLGT in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.7K in Q4 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • SBI Securities held 312 shares of Fulgent Genetics worth $6.4K as of Q2 2026.
  • SBI Securities sold 700 Fulgent Genetics shares in Q2 2026, an estimated $11.9K.
  • Fulgent Genetics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2062 holding.
  • SBI Securities first reported a position in Fulgent Genetics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Fulgent Genetics position peaked at $29.7K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.